Article info

PDF

Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI)

Authors

  1. Correspondence to Professor Peter Pickkers; peter.pickkers{at}radboudumc.nl
View Full Text

Citation

Peters E, Mehta RL, Murray PT, et al
Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI)

Publication history

  • Received April 21, 2016
  • Revised June 15, 2016
  • Accepted August 15, 2016
  • First published September 27, 2016.
Online issue publication 
September 27, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.